skip to Main Content

Role of Chemoradiation in Resectable Pancreatic Cancer

Newsfeed image, light gray text on dark gray background
John L. Marshall, MD; Tanios S. Bekaii-Saab, MD; Eileen M. O’Reilly, MD; Kabir Mody, MD; and George P. Kim, MD, share insight on identifying patients with borderline resectable pancreatic cancer and discuss chemoradiotherapy versus immediate surgery, based on data from the phase III PREOPANC-1 trial. 

Watch or listen to the video here . . .

Back To Top